Ritu Arya

Ritu Arya practices at Texas Oncology PA in Arlington, Texas.

Ritu Arya's NPI, 1669859377, was assigned on May 1, 2015. Ritu Arya graduated from Duke University School Of Medicine in 2015. Ritu Arya's Illinois license number on file is 125067916.

Ritu Arya's primary practice is Texas Oncology PA, at 906 W Randol Mill Rd, Arlington, TX 76012 in Tarrant County. The practice phone is (972) 997-8000.

Ritu Arya's primary practice is Texas Oncology PA in Arlington, Texas. Ritu Arya is also affiliated with Texas Health Arlington Memorial Hospital. The medical group on file is Texas Oncology. Dmand AI also links Ritu Arya to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ritu Arya practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Ritu Arya's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Ritu Arya is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Ritu Arya's licenses on file in 5 states: Illinois, Texas, Connecticut, Indiana and Pennsylvania.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Ritu Arya treats.

CMS data shows 3,939 Medicare services from Ritu Arya across 27 procedure codes in 2024, for 156 Medicare patients. Medicare paid $456,519 for them. Every service was in an office.

CMS counts 156 Medicare patients who saw Ritu Arya in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ritu Arya's median patient age at 70, with 61% women.

In 2024, Ritu Arya wrote 182 Medicare Part D claims for 89 patients. 95% of them were for generic drugs. CMS names the drug for 98 of them, across 5 drugs with 11 or more claims each, at $1,442 in total drug cost. In 2023, CMS named 91 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Ritu Arya for performance year 2024, reported through an alternative payment model (APM). Ritu Arya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Ritu Arya, published from 2014 to 2023. 2015 was the busiest year, with 4. The most frequent topics are Radiotherapy Dosage, Brachytherapy and Radiotherapy Planning, Computer-Assisted. Ritu Arya has published most often in Pract Radiat Oncol. Ritu Arya's most frequent co-authors are Anne R. McCall, MD, Daniel William Golden, MD and Christina H. Son.

CMS Open Payments shows 11 general payments to Ritu Arya from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $150.

Ritu Arya graduated from Duke University School Of Medicine in 2015.

Ritu Arya is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.